Akums Drugs and Pharmaceuticals has informed that pursuant to regulation 30 read with Part A of Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Akums Drugs and Pharmaceuticals will be interacting with the Analysts / Investors, details of the meetings are enclosed.
The above information is a part of company’s filings submitted to BSE.